Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist

被引:46
作者
Feng, Song [1 ]
Yang, Minmin [1 ]
Zhang, Zhenshan [1 ]
Wang, Zhanguo [1 ]
Hong, Di [1 ]
Richter, Hans [2 ]
Benson, Gregory Martin [2 ]
Bleicher, Konrad [2 ]
Grether, Uwe [2 ]
Martin, Rainer E. [2 ]
Plancher, Jean-Marc [2 ]
Kuhn, Bernd [2 ]
Rudolph, Markus Georg [2 ]
Chen, Li [1 ]
机构
[1] Roche R&D Ctr China Ltd, Shanghai 201203, Peoples R China
[2] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland
关键词
Farnesoid X receptor (FXR); Agonist; N-Oxide pyridine; Isoxazole; NUCLEAR RECEPTOR FXR; BILE-ACIDS; FEEDBACK-REGULATION; ACTIVATION; BINDING; LIGANDS; MICE;
D O I
10.1016/j.bmcl.2009.03.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
According to the docking studies and the analysis of a co-crystal structure of GW4064 with FXR, a series of 3-aryl heterocyclic isoxazole analogs were designed and synthesized. N-Oxide pyridine analog (7b) was identified as a promising FXR agonist with potent binding affinity and good efficacy, supporting our hypothesis that through an additional hydrogen bond interaction between the pyridine substituent of isoxazole analogs and Tyr373 and Ser336 of FXR, binding affinity and functional activity could be improved. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2595 / 2598
页数:4
相关论文
共 29 条
[1]   Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064 [J].
Akwabi-Ameyaw, Adwoa ;
Bass, Jonathan Y. ;
Caldwell, Richard D. ;
Caravella, Justin A. ;
Chen, Lihong ;
Creech, Katrina L. ;
Deaton, David N. ;
Jones, Stacey A. ;
Kaldor, Istvan ;
Liu, Yaping ;
Madauss, Kevin P. ;
Marr, Harry B. ;
McFadyen, Robert B. ;
Miller, Aaron B. ;
Navas, Frank, III ;
Parks, Derek J. ;
Spearing, Paul K. ;
Todd, Dan ;
Williams, Shawn P. ;
Wisely, G. Bruce .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (15) :4339-4343
[2]   Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor [J].
Ananthanarayanan, M ;
Balasubramanian, N ;
Makishima, M ;
Mangelsdorf, DJ ;
Suchy, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28857-28865
[3]  
Bell M. G., 2007, WO Pat., Patent No. [WO2007092751A2, 2007092751]
[4]  
Bell M. G., 2007, Patent, Patent No. [WO 2007140183 A1, 2007140183, WO2007140183A1]
[5]  
Bell M. G., 2007, WO Pat., Patent No. [WO2007140174A2, 2007140174]
[6]   The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice [J].
Cariou, B ;
van Harmelen, K ;
Duran-Sandoval, D ;
van Dijk, TH ;
Grefhorst, A ;
Abdelkarim, M ;
Caron, S ;
Torpier, G ;
Fruchart, JC ;
Gonzalez, FJ ;
Kuipers, F ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (16) :11039-11049
[7]   FXR: a promising target for the metabolic syndrome? [J].
Cariou, Bertrand ;
Staels, Bart .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (05) :236-243
[8]   Identification of gene-selective modulators of the bile acid receptor FXR [J].
Dussault, I ;
Beard, R ;
Lin, M ;
Hollister, K ;
Chen, J ;
Xiao, JH ;
Chandraratna, R ;
Forman, BM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7027-7033
[9]   Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation [J].
Fujino, T ;
Une, M ;
Imanaka, T ;
Inoue, K ;
Nishimaki-Mogami, T .
JOURNAL OF LIPID RESEARCH, 2004, 45 (01) :132-138
[10]   A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis [J].
Goodwin, B ;
Jones, SA ;
Price, RR ;
Watson, MA ;
McKee, DD ;
Moore, LB ;
Galardi, C ;
Wilson, JG ;
Lewis, MC ;
Roth, ME ;
Maloney, PR ;
Willson, TM ;
Kliewer, SA .
MOLECULAR CELL, 2000, 6 (03) :517-526